Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions. The tool, called EMBeddER (EMBER), ...

Nia Haware and Marcia Pennant work jointly as Legacy Marketing Officers in our Development and Communications Office.

Dr Luis Zapata Ortiz leads a dedicated research group focusing on advancing our understanding of the immune system's role in genetic variability and its implications for disease, cancer and ageing.

A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours. The findings show that the relationship between these cells, known as the ...

Researchers have uncovered new details about the complex relationship between the immune system and cancer. They have shown that this relationship can influence the distribution and frequency of ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

An innovative study has uncovered two genes that promote the formation of prostate tumours. Both genes activate a signalling pathway that plays a part in the growth, division and death of cells and is ...